Univariate logistic regression analysis of predictors of LV recovery (n=141)
| Predictor | Unadjusted OR | 95% CI | p Value |
|---|---|---|---|
| Clinical characteristics | |||
| Age (years) | 1.07 | 1.00 to 1.15 | 0.04 |
| Parity (number) | 1.26 | 0.96 to 1.65 | 0.09 |
| BMI (kg/cm2) | 1.02 | 0.95 to 1.10 | 0.54 |
| Systolic blood pressure (mm Hg) | 1.02 | 0.99 to 1.05 | 0.07 |
| Heart rate (beats/min) | 0.98 | 0.96 to 1.00 | 0.06 |
| NYHA functional class | 0.74 | 0.41 to 1.35 | 0.33 |
| Medication | |||
| Carvedilol (yes, no) | 0.80 | 0.35 to 1.80 | 0.58 |
| ACE inhibitor (yes, no) | 0.93 | 0.34 to 2.57 | 0.89 |
| Furosemide (yes, no) | 2.25 | 0.27 to 18.75 | 0.45 |
| Digoxin (yes, no) | 0.95 | 0.42 to 2.16 | 0.90 |
| Echocardiography | |||
| LVEDD (mm) | 0.93 | 0.88 to 0.99 | 0.025 |
| LVESD (mm) | 0.93 | 0.87 to 0.98 | 0.01 |
| Ejection fraction (%) | 1.03 | 0.98 to 1.08 | 0.27 |
| E/A | 0.56 | 0.31 to 1.02 | 0.057 |
| Deceleration time (ms) | 1.00 | 0.99 to 1.01 | 0.90 |
| LV thrombus | 1.93 | 0.60 to 6.25 | 0.27 |
| Laboratory | |||
| Haemoglobin (g/dl) | 1.33 | 1.05 to 1.69 | 0.02 |
| Creatinine (mmol/l) | 0.96 | 0.93 to 0.98 | 0.0008 |
| Urea (mmol/l) | 0.94 | 0.79 to 1.13 | 0.51 |
| Total protein (g/l) | 1.01 | 0.98 to 1.05 | 0.51 |
| Albumin (g/l) | 1.02 | 0.99 to 1.04 | 0.10 |
| Total bilirubin (μmol/l) | 0.99 | 0.95 to 1.02 | 0.42 |
| Direct bilirubin (μmol/l) | 0.98 | 0.92 to 1.03 | 0.40 |
| Indirect bilirubin (μmol/l) | 0.99 | 0.93 to 1.05 | 0.64 |
| Alkaline phosphatase (U/l) | 1.01 | 0.99 to 1.01 | 0.11 |
| AST (U/l) | 0.99 | 0.98 to 1.01 | 0.33 |
| ALT (U/l) | 0.99 | 0.99 to 1.01 | 0.45 |
| GGT (U/l) | 1.00 | 0.99 to 1.01 | 0.73 |
| Total cholesterol (mmol/l) | 1.10 | 0.76 to 1.61 | 0.61 |
ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; GGT, γ-glutamyl transpeptidase; LV, left ventricular; LVEDD, LV end diastolic diameter; LVESD, LV end systolic diameter; NYHA, New York Heart Association.